Medical imaging and radiology
Aidoc
Clinical AI platform for radiology and enterprise imaging workflows.
Last updated: June 5, 2026
Back to directoryRetinAI Discovery medical AI product profile
Ophthalmology data and image-management platform with certified Discovery products and AI modules for retinal imaging workflows.
Medical imaging and radiology
Best fit
Teams managing multimodal retinal imaging data, clinical studies, retina RWE datasets, or clinic workflows that need secure sharing and specialist-reviewed AI enrichment.
- Primary use case
- Ophthalmology image and data platform with OCT/image management, AI enrichment, trial data collection, and retinal-disease analytics
- Audience
- Ophthalmology clinics, retina research groups, clinical-study teams, pharma teams, and real-world evidence programs
- Risk level
- Medium to high
- Pricing signal
- Enterprise, clinical-study, and clinic pricing vary by module and region; verify current product, AI module, and support terms.
- Official sources
- 5 official sources
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating RetinAI Discovery as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Confirm device status by region and module, because the Discovery platform, CE-marked AI modules, FDA-cleared platform claims, and U.S. RUO AI-module limits may differ. |
|---|---|
| Privacy | Review DICOM/proprietary image storage, data-sharing permissions, real-world evidence reuse, role access, cloud hosting, GDPR/HIPAA/PIPEDA posture, DPA terms, and study contracts. |
| Evidence | Assess validation for the exact retinal disease, OCT/device source, AI module, endpoint, and clinic or research workflow before relying on extracted measurements. |
| Workflow | Best governed as a secure retinal imaging data and AI-enrichment layer with ophthalmologist, reader, or study-team review before clinical or trial decisions. |
Where RetinAI Discovery fits
RetinAI describes Discovery as a vendor-neutral ophthalmology image and data platform with AI enrichment, Discovery for clinics and clinical studies, GDPR/HIPAA/PIPEDA privacy claims, CE-marked Discovery and AI modules, FDA-cleared Discovery platform status, and U.S. research-use-only limits for several AI modules.
Not for: Using U.S. research-use-only AI modules for clinical diagnosis, replacing ophthalmologist interpretation, or deploying without region-specific device-status review.
What to verify before using RetinAI Discovery
- Which Discovery product, AI module, disease area, and region are in scope for clinical use versus research use only.
- FDA-cleared and CE-marked status for the platform and each AI module, including any U.S. RUO limits for biomarkers, fluid, or layer segmentation.
- How DICOM and proprietary images, OCT data, patient identifiers, access controls, sharing, retention, and data-processing terms work.
- How ophthalmologists, study readers, or researchers review AI-derived outputs and manage measurement, segmentation, or endpoint disagreements.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- www.retinai.com / products / discovery
- www.retinai.com
- www.retinai.com / about-us
- www.retinai.com / privacy-policy
- www.retinai.com / data-processing-agreement
Related medical AI products
Medical imaging and radiology
Viz.ai
AI-powered care coordination platform with imaging-driven alerts across therapeutic areas.
Medical imaging and radiology
Ferrum Health
Clinical AI governance and deployment platform for health systems adopting multiple imaging or clinical AI models.
Medical imaging and radiology
Blackford Platform
Enterprise medical imaging AI platform for evaluating, deploying, routing, and monitoring multiple radiology AI applications.